Skip to content
Kalpvruksh Markets
Offline Log in

AVIENCENSEOffline

Avience Biomedicals · INE0V9I01017
255.00+12.10 (+4.98%)last close · 05 Nov 2026
Prev close
242.90
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
—

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • FPI −3.0 pp · DII −5.5 pp · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.1×
median 13,200
Delivered
14,400
Of volume
86%

Price & trend

Price & trend

Not enough price historyFigures need 60 sessions of NSE prices.

Ownership

Who owns the company

% of all shares, by quarter

GroupJun 26Sep 26
Promoters64.6%64.6%
FPI3.1%0.0% −3.0
Mutual funds0.3%—
Other DII8.7%3.5% −5.3
Individuals13.6%18.4% +4.8
Others9.8%13.5% +3.7

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 26 noneSep 26 none

Holders

Sep 26

All shareholders
719
Individuals
621

Which funds bought and sold

No fund holds this companyNo Indian mutual fund disclosed a position at the last quarter end.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Avience Biomedicals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
    08 Sept 2026
  • Board outcome
    Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    26 Aug 2026
  • Board outcome
    Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    17 Jul 2026
  • Bulk deal: BUY
    42,000 at ₹245.38 — SURESH ZUNZUNWALA
    20 Jul 2026
  • Bulk deal: SELL
    42,000 at ₹265.55 — SURESH ZUNZUNWALA
    20 Jul 2026
  • Bulk deal: SELL
    37,800 at ₹240.99 — KASHMIRA AJAY PATEL
    17 Jul 2026
  • Bulk deal: BUY
    18,600 at ₹229.06 — MANSI SHARE AND STOCK BROKING PRIVATE LIMITED
    17 Jul 2026

Latest shown; 8 in six months on all disclosures.

AVIENCE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.